Filing Flows

Filing Flows › Guardian Pharmacy Services (GRDN) › Q1 2025

Guardian Pharmacy Services (GRDN) Q1 2025 earnings results (first quarter 2025)

10-Q filed May 12, 2025

Guardian Pharmacy Services (GRDN) reported revenue of $329M for the first quarter 2025 (Q1 2025), +20% from a year earlier and -3% from the quarter before. Operating margin was 3.9%, net earnings $9.4M (2.9% of revenue).

Revenue$329M
Year over year+20%
Quarter over quarter-3%
Operating margin3.9%
Net earnings$9.4M

Guardian Pharmacy Services, Q1 2025: revenue $329M (+20% year over year), operating margin 3.9%, net earnings $9.4M, operating cash flow $17.6M. The chart follows the revenue to costs, profit and cash.

Q1 2025AmountQ/QY/Y
Revenue$329M-3%+20%
Gross profit$64.3M-4%+17%
Operating profit$13.0M-22%+64%
Net earnings$9.4M-21%+239%
Operating cash flow$17.6M-21%+103%
Free cash flow$11.7M-42%+137%

What changed

Revenue was $329.3M in Q1 2025, up 20% year over year and down 3% from the previous quarter.

Gross margin was 19.5%, down 0.5 points from a year earlier. Operating profit was $13.0M, a 3.9% margin (up 1.1 points year over year). Of the extra revenue versus a year earlier, 9% reached operating profit, above the 3% margin then. Operating expenses grew 9% against revenue growth of 20%. Net earnings were $9.4M, up 239% year over year. The effective tax rate was 29.2%.

Operating cash flow was $17.6M (up 103% year over year), 189% of net earnings. Non-cash charges added back $5.3M of depreciation and amortization and $4.0M of share-based compensation. Working capital and other items used $1.0M. Capital expenditures of $5.8M left free cash flow of $11.7M.

Questions

What was Guardian Pharmacy Services' revenue in the first quarter 2025?

Guardian Pharmacy Services (GRDN) reported revenue of $329M for the first quarter 2025 (Q1 2025), +20% from a year earlier and -3% from the quarter before.

Was Guardian Pharmacy Services profitable in the first quarter 2025?

Operating profit was $13.0M (3.9% of revenue) and net earnings $9.4M.

Open the interactive Sankey →

Source: Guardian Pharmacy Services 10-Q on SEC EDGAR.